Medicinske patienter med høj risiko for tromboemboliske komplikationer ud fra en individuel risikovurdering Den anbefalede dosis fondaparinux er 2, 5 mg én gang daglig, der indgives som subkutan injektion.
Medical patients who are at high risk for thromboembolic complications based on an individual risk assessment The recommended dose of fondaparinux is 2.5 mg once daily administered by subcutaneous injection.